Watch: Biogen’s market value rose $11 bln on news its new treatment for the disease appeared effective. rob_cyran explains why this rise is rather cautious, and how the drug might exceed Wall Street’s assumptions:
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ken Griffin finds buyer for the Near North Side condo he listed for $11.5MBillionaire Ken Griffin has found a buyer for the five-bedroom, 7,400-square-foot Near North Side condominium that he long has called his home, just weeks after he placed it on the market for $11.5 million.
Read more »
BVTV: War and global warming | Reuters VideoRussia’s invasion has prompted countries to boost gas production and burn more coal. Climate diplomacy is on ice. But this crisis will also prompt a dash for cheaper and more secure renewable energy. That helps the fight against climate change, Hugo Dixon tells Peter Thal Larsen.
Read more »
Alzheimer’s Drug Slows Disease Progression in TrialEisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of approval.
Read more »
Alzheimer's drug slowed progression of the disease in Phase 3 trialThe Japanese drugmaker Eisai said Tuesday its experimental drug for Alzheimer’s disease helped slow cognitive decline in patients in the early stages of the illness.
Read more »
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug successBiogen and partner Eisai late Tuesday reported positive results from a late stage, large trial of their experimental Alzheimer's drug.
Read more »